Samir Kaul, Director at Guardant Health, Inc. (GH), sold 19,200 shares at $88.71 ($1.7M) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Open-market sale of $1.7M GH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.18 | 300 | $26K | 1.5% |
| 2 | $86.82 | 4,501 | $391K | 23.2% |
| 3 | $86.82 | 4,501 | $391K | 23.2% |
| 4 | $87.86 | 2,422 | $213K | 12.7% |
| 5 | $87.86 | 2,422 | $213K | 12.7% |
| 6 | $88.71 | 2,277 |
| $202K |
| 12.0% |
| 7 | $88.71 | 2,277 | $202K | 12.0% |
| 8 | $89.44 | 500 | $45K | 2.7% |
| Total | $87.57 avg | 19,200 | $1.7M | 100% |
| Filing → |
| GH | SELL | 2020-10-20 | $2.0M | — | Filing → |
| GH | SELL | 2020-09-21 | $1.8M | — | Filing → |
| GH | SELL | 2020-03-06 | $2.1M | — | Filing → |